Patients within a well-organized, high-volume, urban ST-segment elevation myocardial infarction network were found to have comparable management and 1-year outcomes when admitted in a primary percutaneous coronary intervention center during on-hours or off-hours.
Researchers assessed the demographics associated with the admission of acute myocardial infarction and evaluated the differences between rheumatoid arthritis and gout and osteoarthritis.
Patients admitted to the hospital for myocardial infarction with a known diagnosis of obstructive sleep apnea were found to have improved in-hospital mortality.
Estimated pulse wave velocity predicted outcomes independent of the Framingham Risk Score, indicating an incremental role of markers of aortic stiffness on cardiovascular risk.
Compared with current standard of care, implantation of a device for intracardiac ST-segment monitoring and alerting in people who are at high risk for recurrent ACS resulted in a significant decrease in median pre-hospital delay.
Use of sex-specific thresholds identified 5 times more additional women than men with myocardial injury.
Study data indicate a significantly increased risk for MACE among patients with depressive disorder who have early or late stage ACS.
Study demonstrates for the first time in a randomized trial a return of vasomotion after device resorption by the use of bioresorbable scaffold technology in comparison to permanent drug-eluting stent.
A new study suggests that when evaluating nonculprit lesions in patients with STEMI with multivessel disease who have been reperfused, CMR and FFR have moderate-to-good agreement.
Remote ischemic conditioning was not linked to improved clinical outcomes at 12 months in patients with STEMI undergoing PCI.
